clinical trial drugs

clinical trial drugs

Algernon Pharmaceuticals: Advancing DMT into a Phase 1 Clinical Trial

Algernon is focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease.

Algernon is focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease.

October 28, 2022

Latest

CEO Clips - North American Iron: Securing America’s Steel Future Sustainably Metals & Mining

Invest Yukon: A Fresh Look at One of Canada’s Most Undervalued Mining Regions Metals & Mining

Mayfair Gold: Advancing a Modern Vision for Gold Mining Metals & Mining

Hot Companies